Key result
Cardiovascular trials underrepresent elderly patients, highlighting an urgent need to evaluate outcomes in older cohorts.
Why the study?
There is a paucity of data to guide clinical cardiovascular management in elderly patients, contributing to lesser use of beneficial therapies in this population.
Population
Elderly patients with cardiovascular disease
Comparison
Inclusion versus non-inclusion in clinical research studies
Design
Review
Authors
Loading...
May warrant cautious therapy application in advanced age; leaves open optimal strategies pending dedicated elderly trials.
This review emphasizes the critical need to include elderly patients in cardiovascular clinical trials to better guide management and improve outcomes in this population.
Nanette Kass Wenger (2006) conducted a review in Cardiovascular disease in elderly patients. Cardiovascular clinical trials currently lack sufficient data on elderly patients, mandating their inclusion in future research to evaluate functional independence, quality of life, and survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: